Nanotechnology and pancreatic cancer management: State of the art and further perspectives

Pancreatic ductal adenocarcinoma (PDAC) represents a leading cause of cancer death and is often diagnosticated too late to allow adequate treatments. Lots of biomarkers have been discovered in lasts years but, to date, there is a lack of low-cost and non-invasive tools for PDAC early detection. None...

Descripción completa

Detalles Bibliográficos
Autores principales: Caputo, Damiano, Pozzi, Daniela, Farolfi, Tommaso, Passa, Roberto, Coppola, Roberto, Caracciolo, Giulio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040067/
https://www.ncbi.nlm.nih.gov/pubmed/33889275
http://dx.doi.org/10.4251/wjgo.v13.i4.231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040067/
https://www.ncbi.nlm.nih.gov/pubmed/33889275
http://dx.doi.org/10.4251/wjgo.v13.i4.231

Ejemplares similares